CABA Market Cap History
Below is a table of the CABA market cap history going back to 10/25/2019:

Date CABA Market Cap
10/25/2019161.43M
12/5/2019292.25M
3/20/2020176.17M
5/8/2020184.10M
7/29/2020291.72M
11/2/2020275.44M
3/10/2021289.96M
4/29/2021284.18M
7/30/2021186.30M

Also see: CABA Shares Outstanding History
and CABA YTD Return
CABA Historical Market Cap:
+8.46% CAGR
CABA Historical Market Cap: +8.46% CAGR

Mouse over chart for data details
10/25/201912/5/20193/20/20205/8/20207/29/202011/2/20203/10/20214/29/20217/30/2021
Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Co.'s key product candidate, DSG3-CAART, is being evaluated for the treatment of mucosal pemphigus vulgaris (mPV), a subtype of PV that affects mucosal surfaces. Co.'s key preclinical product candidate, MuSK-CAART, is designed to treat a subset of patients with myasthenia gravis. Co. is also developing other product candidates in discovery-stage or preclinical development for the treatment of mucocutaneous PV, and Hemophilia A with Factor VIII, or FVIII, alloantibodies in addition to three undisclosed targets. We show 9 historical shares outstanding datapoints in our CABA shares outstanding history coverage, used to compute CABA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CABA market cap history over the course of time is important for investors interested in comparing CABA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CABA versus a peer is one thing; comparing CABA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CABA can fluctuate over the course of history. With this page we aim to empower investors researching CABA by allowing them to research the CABA market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree CABA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Cabaletta Bio (CABA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

CADL Market Cap History
CAH Market Cap History
CALA Market Cap History
CAPR Market Cap History
CARA Market Cap History
CASI Market Cap History
CASM Market Cap History
CATB Market Cap History
CATS Market Cap History
CBAY Market Cap History
More Healthcare companies »

 

CABA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.